I don't think this is the last roll of the dice, I was being somewhat sarcastic. They really have other financing possibilities in my view.  I am really in it for the BTD and all the possibilities of Apabetalone being a homerun. If they can generate revenue short-term with Covid then it is worth a try given the recent peer-reviewed papers. Who knows maybe it will give us a position of strength in negotiations going forward. This has to happen in a fairly timely manner before a Pfizer or someone beats us to the mark on covid therapeutic. Also maybe now we can make some positive steps towards the BTD.